Mar 04, 2022 / Comment Letters

MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 04, 2022 / Presentations

Improving Medicare Advantage risk adjustment by limiting the influence of outlier predictions

Research Areas:

Private Plans

Mar 04, 2022 / Presentations

Integrating episode-based payment with population-based payment

Research Areas:

Physicians And Other Health Professionals

Mar 03, 2022 / Comment Letters

MedPAC comment on CMS’s notice of proposed rulemaking on Medicare Advantage coding

Research Areas:

Private Plans

Mar 03, 2022 / Presentations

Opportunities to strengthen the geriatric workforce

Research Areas:

Physicians And Other Health Professionals

Mar 03, 2022 / Presentations

Medicare payment policies to support safety-net providers

Research Areas:

Hospitals

Mar 03, 2022 / Presentations

Findings from MedPAC’s annual beneficiary and clinician focus groups

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Physicians And Other Health Professionals, Quality

Mar 03, 2022 / Transcripts

Mach 2022 meeting transcript

Research Areas:

Beneficiaries and Coverage, Medicare Spending and Financing, Physicians And Other Health Professionals, Private Plans

Feb 10, 2022 / Comment Letters

MedPAC comment on CMS’s proposed NCD decision memorandum on monoclonal antibodies that target amyloid for the treatment of Alzheimer’s disease

Research Areas:

Drugs, Devices, and Tests

Feb 02, 2022 / Congressional Testimony

Testimony: The Hospital Insurance Trust Fund and the Future of Medicare Financing (Senate Finance)

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans, Quality